Belani CP - Search Results

1

Advanced NSCLC patients with high IL-6 levels have altered peripheral T cell population and signaling.

Rice SJ, Liu X, Zhang J, Jia B, Zheng H, Belani CP. Rice SJ, et al. Among authors: belani cp. Lung Cancer. 2019 May;131:58-61. doi: 10.1016/j.lungcan.2019.03.014. Epub 2019 Mar 18. Lung Cancer. 2019. PMID: 31027698

2

Development of docetaxel in advanced non-small-cell lung cancer.

Belani CP, Eckardt J. Belani CP, et al. Lung Cancer. 2004 Dec;46 Suppl 2:S3-11. doi: 10.1016/s0169-5002(04)80036-9. Lung Cancer. 2004. PMID: 15698529 Review.

3

Optimizing chemotherapy for advanced non-small cell lung cancer: focus on docetaxel.

Belani CP. Belani CP. Lung Cancer. 2005 Dec;50 Suppl 2:S3-8. Lung Cancer. 2005. PMID: 16557668 Review.

4

Effect of chemotherapy for advanced non-small cell lung cancer on patients' quality of life. A randomized controlled trial.

Belani CP, Pereira JR, von Pawel J, Pluzanska A, Gorbounova V, Kaukel E, Mattson KV, Ramlau R, Szczesna A, Fidias P, Millward M, Fossella F; TAX 326 study group. Belani CP, et al. Lung Cancer. 2006 Aug;53(2):231-9. doi: 10.1016/j.lungcan.2006.05.003. Epub 2006 Jun 19. Lung Cancer. 2006. PMID: 16787687 Clinical Trial.

5

Women and lung cancer: epidemiology, tumor biology, and emerging trends in clinical research.

Belani CP, Marts S, Schiller J, Socinski MA. Belani CP, et al. Lung Cancer. 2007 Jan;55(1):15-23. doi: 10.1016/j.lungcan.2006.09.008. Epub 2006 Nov 3. Lung Cancer. 2007. PMID: 17084482 Review.

6

Cetuximab in combination with carboplatin and docetaxel for patients with metastatic or advanced-stage nonsmall cell lung cancer: a multicenter phase 2 study.

Belani CP, Schreeder MT, Steis RG, Guidice RA, Marsland TA, Butler EH, Ramalingam SS. Belani CP, et al. Cancer. 2008 Nov 1;113(9):2512-7. doi: 10.1002/cncr.23902. Cancer. 2008. PMID: 18816622 Free article. Clinical Trial.

7

Efficacy and safety of pemetrexed maintenance therapy versus best supportive care in patients from East Asia with advanced, nonsquamous non-small cell lung cancer: an exploratory subgroup analysis of a global, randomized, phase 3 clinical trial.

Belani CP, Wu YL, Chen YM, Kim JH, Yang SH, Zhang L, Peterson P, Orlando M. Belani CP, et al. J Thorac Oncol. 2012 Mar;7(3):567-73. doi: 10.1097/JTO.0b013e31823d4f9d. J Thorac Oncol. 2012. PMID: 22157370 Free article. Clinical Trial.

8

Single agent maintenance therapy for advanced stage non-small cell lung cancer: a meta-analysis.

Behera M, Owonikoko TK, Chen Z, Kono SA, Khuri FR, Belani CP, Ramalingam SS. Behera M, et al. Among authors: belani cp. Lung Cancer. 2012 Aug;77(2):331-8. doi: 10.1016/j.lungcan.2012.03.019. Epub 2012 Apr 28. Lung Cancer. 2012. PMID: 22546678 Free PMC article.

9

Small-cell lung cancer: an update on targeted therapies.

Joshi M, Ayoola A, Belani CP. Joshi M, et al. Among authors: belani cp. Adv Exp Med Biol. 2013;779:385-404. doi: 10.1007/978-1-4614-6176-0_18. Adv Exp Med Biol. 2013. PMID: 23288650 Review.

10

Matched-pair and propensity score comparisons of outcomes of patients with clinical stage I non-small cell lung cancer treated with resection or stereotactic radiosurgery.

Varlotto J, Fakiris A, Flickinger J, Medford-Davis L, Liss A, Shelkey J, Belani C, DeLuca J, Recht A, Maheshwari N, Barriger R, Yao N, DeCamp M. Varlotto J, et al. Cancer. 2013 Aug 1;119(15):2683-91. doi: 10.1002/cncr.28100. Epub 2013 Apr 19. Cancer. 2013. PMID: 23605504 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

293 results

Search Page